Healthcare -
Biotechnology - NASDAQ - US
$ 8.27
-7.86 %
$ 368 M
Market Cap
-4.78
P/E
CADL - TOTAL CURRENT LIABILITIES
Total Current Liabilities CADL - Candel Therapeutics, Inc.
14.2 M
LAST VALUE
62.64%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR